Jane Street Group, LLC P Lx Pharma Inc. Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.12 - $0.3 $6,644 - $16,611	-55,371 Reduced 28.76%	137,133 $17,000
Q4 2022 Feb 14, 2023	BUY	$0.15 - $0.63 $28,875 - $121,277	192,504 New	192,504 $30,000
Q1 2022 May 17, 2022	SELL	$3.54 - $8.3 $165,448 - $387,917	-46,737 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$7.69 - $19.66 $1.06 Million - $2.72 Million	-138,479 Reduced 74.77%	46,737 $374,000
Q3 2021 Nov 16, 2021	BUY	$12.22 - $21.28 $2.1 Million - $3.65 Million	171,586 Added 1258.88%	185,216 $3.58 Million

Q2 2021 Aug 16, 2021	BUY	$9.0 - $15.94 $122,670 - $217,262	13,630 New	13,630 $188,000

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.